It has been reported that hypermethylation of the CpG islands located in the promoter region of the stem/precursor cell marker CD44, one of the colorectal and other cancer stem cell surface markers, might predict biochemical recurrence in prostate cancer patients undergoing radical prostatectomy[47]. The gene discussed is CD44; the disease is Familial prostate cancer.